The dominant logic of Big Tech in healthcare and pharma

被引：7
|
作者：
Schuhmacher, Alexander [1 ,2 ]
Haefner, Naomi [2 ]
Honsberg, Katharina [3 ]
Goldhahn, Jorg [4 ]
Gassmann, Oliver [2 ]
机构：
[1] TH Ingolstadt, THI Business Sch, Esplanade 10, D-85049 Ingolstadt, Germany
[2] Univ St Gallen, Inst Technol Management, Dufourstr 40a, CH-9000 St Gallen, Switzerland
[3] PricewaterhouseCoopers AG, Birchstr 160, CH-8050 Zurich, Switzerland
[4] Swiss Fed Inst Technol, D HEST, HCP H15-3, Leopold Ruzicka Weg 4, CH-8093 Zurich, Switzerland
来源：
DRUG DISCOVERY TODAY | 2023年 / 28卷 / 02期
关键词：
Big Tech; digital; healthcare; pharma; business model; ONCOLOGY;
D O I：
10.1016/j.drudis.2022.103457
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Digital health and digital pharma are considered supportive tools for patients and healthcare providers (HCPs), making the market highly attractive for industry players. Not surprisingly, Tech Giants have started to move into this area. We utilized established management models and publicly available information sources, such as annual company reports, and performed a thorough analysis to uncover the underlying business models of Alphabet, Amazon, Apple, IBM, and Microsoft in order to better understand their intention and course of entering the healthcare and pharma industries. Our results indicate that Big Tech or Tech Giants do address the needs of patients and physicians, while having built clear value propositions, value chains, and revenue models to sustainably revolutionize the healthcare and pharma industries.
引用
收藏
页码：1 / 8
页数：8
相关论文
共 50 条
12345